The neurobiology of pain

Lancet

Volumn 353, Issue 9164, 1999, Pages 1610-1615

  Besson, J M ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; GLUTAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM CHANNEL;

ANALGESIA; HUMAN; INFLAMMATION; NEUROBIOLOGY; NEUROPATHY; PAIN; PRIORITY JOURNAL; REVIEW; SPINAL CORD NERVE CELL;

EID: 0033535722     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)01313-6     Document Type: Review

References (48)

1. Melzack R., Wall P.D. Pain mechanisms: a new theory. Science Wash CD. 150:1965;971-979.
2. Kieffer B.L. Molecular aspects of opioid receptors. Dickenson A.H., Besson J.M. Handbook of experimental pharmacology: the pharmacology of pain. 1997;281-303 Springer, Berlin.
3. Cao Y.Q., Mantyh P.W., Carlson E.J., Gillepsie A.M., Epstein C.J., Basbaum A.I. Primary afferent tachykinins are required to experience moderate to intense pain. Nature. 392:1998;334-335.
4. Zimmer A., Zimmer A.M., Baffi J.et al. Hypoaklgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci USA. 95:1998;2630-2635.
5. De Felipe C., Herrero J.F., O'Brien J.A.et al. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature. 392:1998;334-335.
6. Woolf C.J., Mannion R.J., Neumann S. Null mutations lacking substance: eludicating pain mechanisms by genetic pharmacology. Neuron. 20:1998;1063-1066.
7. Cervero, F., Laird, J.M.A. Visceral pain. Lancet (in press).
8. Woolf, C.J., Mannion, R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet (in press).
9. Belmonte C., Cervo F. Neurobiology of nociceptors. 1996;Oxford University Press, Oxford.
10. Meyer R.A., Campbell J.N., Raja N. Peripheral neural mechanisms of nociception. Wall P.D., Melzack R. 1994;13-14 Churchill Livingstone, Edinburgh.
11. Dray A. Kinins and their receptors in hyperalgesia. Can J Pharmacol. 75:1997;704-712.
12. Schaible H., Grubb B.D. Afferent and spinal mechanisms of joint pain. Pain. 55:1993;5-54.
13. Carlton S.M., Coggeshall R.E. Nociceptive integration: does it have a peripheral component? Pain Forum. 7:1998;71-78.
14. Cesare P., McNaughton P. Peripheral pain mechanisms. Cur Opin Neurobiol. 7:1977;493-495.
15. Dickenson, A.H., Besson, J.M., eds. The Pharmacology of pain, handbook of experimental pharmacology, vol. 130. Berlin: Springer, 1997.
16. Levine J.D., Fields H.L., Basbaum A.I. Peptides and the primary afferent nociceptor. J Neurosci. 13:1993;2273-2286.
17. Rang H.P., Urban L. New molecules in analgesia. Br J Anaesth. 75:1995;145-156.
18. Hökfelt T., Zhang X., Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implication. Trends Neurosci. 17:1994;22-30.
19. Jänig W., Levine J.D., Michaelis M. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. Prog Brain Res. 113:1996;161-184.
20. McMahon S.B., Bennett D.L.H. Growth factors and pain. Dickenson A.M., Besson J.M. 1997;135-160 Springer, Berlin.
21. Xie W., Chapman J.G., Robertson D.L.et al. Expression of a mitogen-responsive gene encoding prostaglandin H synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA. 88:1991;2692-2696.
22. Picot D., Loll P.J., Garavito N. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature. 367:1994;243-249.
23. Vane J.R., Botting R.M. New insight into the mode of action of anti-inflammatory drugs. Inflamm Res. 44:1995;1-10.
24. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptors: a heat-activated ion channel in the pain pathway. Nature. 389:1997;816-824.
25. Tominaga M., Caterina M.J., Malmberg A.B. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 21:1998;531-543.
26. Burnstock G., Wood J.N. Purinergic receptors: their role in nociception and primary afferent neurotransmission. Current Opin Neurobiol. 6:1996;526-532.
27. Waldmann R., Champigny G., Bassilana F., Heurteaux C., Lazdunski M. A proton-gated cation channel involved in acid-sensing. Nature. 386:1997;173-177.
28. Akopian A.N., Sivilotti L., Wood J.N. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature. 379:1996;257-262.
29. Besson J.M., Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol Rev. 67:1987;67-184.
30. Willis W.D., Westlund K.N. Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol. 14:1997;2-31.
31. Dickenson A.H. Spinal cord pharmacology of pain. Br J Anaesth. 75:1995;193-200.
32. Urban L., Thompson S.W.N., Dray A. Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters. TINS. 17:1994;432-438.
33. Jessell T.M., Iversen I.L. Opiate analgesics inhibit substance P release fron rat trigeminal nucleus. Nature. 268:1977;549-551.
34. Mantyh P.W., Demaster E., Malhotra A.et al. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensoty stimulation. Science. 286:1997;1629-1632.
35. Mantyh P.W., Rogers S.D., Honore P.et al. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science. 278:1997;275-279.
36. Dray A., Rang H. The how and why of chronic pain states and the what a new analgesic therapies. TINS. 21:1998;315-317.
37. Meller S.T., Gebhart G.F. NO and nociceptive processing in the spinal cord. Pain. 52:1993;127-136.
38. Malmberg A.B., Yaksh T.L. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science. 257:1992;1276-1279.
39. Rpques B.P., Noble F., Daugé V., Fournié-Zaluski M.C., Beaumont A. Neutral endopeptidase 24.11: structure, inihibition and experimental pharmacology. Pharmacol Rev. 45:1993;118-146.
40. Le Bars D., Besson J.M. The spinal site of action of morphine in pain relief: from basic research to clinical applications. Trends Pharmacol Sci. 2:1981;323-325.
41. Yaksh T.L. Spinal opiate analgesia: characteristics and principles of action. Pain. 11:1981;293-346.
42. Mansour A., Fox C.A., Akil H., Watson S.J. Opiod-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:1996;22-29.
43. Stein, C., Schäfer, M., Cabot, P.J., Zhang, L. & Carter L. opiods and inflammation. In: Borsook, D., ed. Molecular neurobiology of pain, progress in pain research and management. Seattle: IASP Press, 1997; 9: 25-43.
44. Basbaum A.I., Besson J.M. Towards a new pharmacology of pain. 1991;John Wiley & Sons, London.
45. Besson J.M., Guilbaud G., Ollat H. Forebrain areas involved in pain processing. 1995;John Libbey Eurotext, Paris.
46. Perl E. Gettinf a line on pain: is it mediated by dedicated pathways? Nature Neurosci. 1:1998;177-178.
47. Villanueva L., Bernard J.F. The multiplicity of ascending pain pathways. Lydic R., Baghdoyan H.A. Handbook of behavioural state control, cellular and molecular mechanisms. 1999;569-585 CRC Press, Boca Raton.
48. Derbyshire S.W.G., Jones A.K.P., Gyulai F., Clark S., Townsend D., Firestone L.L. Pain processing during three levels of noxious stimulation produced differential patterns of central activity. Pain. 73:1997;431-445.